Sep 9th 2015, 10:14, by O'Connor A, Behan L, Toner M, Kinsella J, Beausang E, Timon C
Evaluating the outcomes of temporal bone resection in metastatic cutaneous head and neck malignancies: 13-year review.
J Laryngol Otol. 2015 Sep 8;:1-6
Authors: O'Connor A, Behan L, Toner M, Kinsella J, Beausang E, Timon C
Abstract
OBJECTIVE: To evaluate the survival outcomes of patients who underwent lateral temporal bone resection as treatment for metastatic skin cancers.
METHODS: A single-institute, retrospective chart review was carried out on patients who underwent lateral temporal bone resection between January 2000 and December 2012. Overall survival and disease-free survival rates were calculated.
RESULTS: Forty-seven patients underwent temporal bone resection for primary (n = 21) or recurrent (n = 26) malignancies. The majority of patients (95.4 per cent) had advanced disease (stage III or IV). Average patient follow-up duration was 45 months. The 5-year and 10-year overall survival rates were 40 per cent and 23 per cent respectively. The five-year disease-free survival rate was 28 per cent.
CONCLUSION: Aggressive initial surgical resection is warranted in the treatment of these tumours.
PMID: 26346979 [PubMed - as supplied by publisher]
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου